Use of Drug-Coated Balloon to Improve Recanalization of a Coronary Chronic Total Occlusion After Failed Angioplasty
IMPROVED-RECTO
1 other identifier
observational
44
1 country
1
Brief Summary
Observational retrospective registry to compare effectiveness of paclitaxel-coated vs. non coated balloon angioplasty proximal to a Chronic Total Occlussion (CTO) after failed revascularization. Primary objective is to determine success rate after repeated percutaneous coronary intervention of a CTO 3 to 6 months after paclitaxel-coated balloon angioplasty proximal to the persistent lesion.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Oct 2018
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2021
CompletedFirst Submitted
Initial submission to the registry
December 2, 2021
CompletedFirst Posted
Study publicly available on registry
December 15, 2021
CompletedApril 22, 2022
April 1, 2022
2 years
December 2, 2021
April 21, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Success of repeated percutaneous coronary intervention of a CTO 3 to 6 months after balloon angioplasty proximal to the persistent lesion.
6 months
Secondary Outcomes (6)
Mortality after second attempt of CTO recanalization
6 months
Quality of life assessed by EQ5D questionnaire
6 months
Procedural duration during second attempt
6 months
Radiation during second attempt
6 months
Contrast administration during second attempt
6 months
- +1 more secondary outcomes
Study Arms (2)
Paclitaxel-coated balloon angioplasty
Patients with previous failed recanalization of a CTO treated with paclitaxel coated balloon immediately proximal to the CTO during the index procedure
Non-coated balloon angioplasty
Patients with previous failed recanalization of a CTO treated with non-coated balloon immediately proximal to the CTO during the index procedure
Interventions
Paclitaxel-coated ballon dilation angioplasty proximal to CTO lesion after failed percutaneous recanalization
Non-coated ballon dilation angioplasty proximal to CTO lesion after failed percutaneous recanalization
Eligibility Criteria
Patients with coronary angiography in which percutaneous coronary intervention results in failure during treatment of a CTO. Indication of the procedures will be clinically driven. Informed consent will be provided after the first failed attempt of CTO recanalization.
You may qualify if:
- Failed recanalization of a CTO in patients with clinical indication for the percutaneous procedure.
- Patient willing to participate in the study providing signed informed consent.
- J-CTO Score ≥2.
You may not qualify if:
- \- Unfeasible recanalization of the CTO according to the interventional cardiologists of the center.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hospital Clínico Universitario de Valladolid
Valladolid, Spain
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Coordinator of Interventional Cardiology Unit
Study Record Dates
First Submitted
December 2, 2021
First Posted
December 15, 2021
Study Start
October 1, 2018
Primary Completion
October 1, 2020
Study Completion
December 1, 2021
Last Updated
April 22, 2022
Record last verified: 2022-04
Data Sharing
- IPD Sharing
- Will not share